Por: RTTNews Health December 20, 2022
Biotechnology company Horizon Therapeutics plc () announced Tuesday that the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.This rare autoimmune disease is caused by inflammation in the central nervous system, resulting in severe and recurrent attacks that can lead to permanent disability, such as paralysis and vision loss. An estimated 10,000... + full article
Forbes USA Business December 26, 2022
Ethan is the CEO of , an award-winning employee activation agency. He's a lecturer at Columbia and Trustee of the Institute for PR. getty More than a decade ago, a friend encouraged me to review the projects in the department I led through the lens of horizon planning.... + más
This Is The Real Reason Your Strategic Plans Constantly Fail | Forbes
Horizon Worlds metaverse app so bad that Meta has to force employees to use it | 9to5Mac
Associated Press USA Business December 12, 2022
Amgen is spending more than $26 billion to dive deeper into rare disease treatments with a deal for drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a thyroid eye disease treatment that... + más
Amgen to buy Horizon Therapeutics in $26.4B deal | 10 WBNS
Amgen to buy Horizon Therapeutics in $26.4B deal | ABC News
RTTNews USA Health December 05, 2022
Nkarta Inc. () is scheduled to report updated clinical data from its ongoing clinical trial of NKX019, its CD19-directed CAR NK cell therapy candidate, today, December 5.The company is developing allogeneic engineered natural killer (NK) cell therapies to treat cancer.NKX019 is... + más
Nkarta Says FDA Clears IND Application For NKX019 To Treat Lupus Nephritis | RTTNews
RTTNews USA Health October 28, 2022
AbbVie () announced Friday that the European Medicines Agency (EMA) has validated a Marketing Authorization Application (MAA) for epcoritamab (DuoBody-CD3xCD20), an investigational subcutaneous bispecific antibody, for the treatment of adult patients with relapsed/refractory... + más
Don’t Pay for Cord-Blood Banking | The Atlantic
Prime Video’s Aparna Purohit Reveals How Madhuri Dixit Got Onboard For ‘Maja Ma’ | Forbes
RTTNews USA Health October 12, 2022
Merck & Co., Inc. (), known as MSD outside the U.S. and Canada, announced Wednesday that Health Canada has granted approval for KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, as monotherapy for the adjuvant treatment of adults with renal cell carcinoma (RCC) at... + más
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients | CNBC
Study: Too few kids with sickle cell get stroke screen, care | Associated Press
The Verge USA Tech October 07, 2022
Meta’s flagship metaverse app is too buggy and employees are barely using it, says exec in chargeMeta’s flagship metaverse app is too buggy and employees are barely using it, says exec in charge / Meta’s Horizon Worlds has so many quality issues that even the team building... + más
To defeat FTC lawsuit, Meta demands 100+ rivals share biggest trade secrets | Ars Technica
9to5Mac USA Tech October 07, 2022
It seems is having problems persuading even its own employees to don one of its headsets and use its primary metaverse app, Horizon Worlds. So much so that an internal memo says the company would “hold managers accountable” for their teams using it. It’s one of a set of... + más
Meta’s VR social network Horizon is too buggy and employees are barely using it | The Verge
When metaverse worlds collide in Congress | The Hill
About iurex | Privacy Policy | Disclaimer |